New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Por um escritor misterioso
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
Long COVID (Post-COVID Conditions, PCC) > Fact Sheets > Yale Medicine
Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020
COVID-19 infection: an overview on cytokine storm and related interventions, Virology Journal
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
Long COVID and its Management
Long covid—mechanisms, risk factors, and management
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study - The Lancet Respiratory Medicine
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Potential therapeutic options for COVID-19: an update on current evidence, European Journal of Medical Research
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
Long COVID and cardiovascular disease: a learning health system approach
What We Know about Long COVID—and What We Don't, The Brink
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial - eClinicalMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)